Cargando…
Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres
INTRODUCTION: The latest European Society of Cardiology Guidelines recommend consideration of a wearable cardioverter-defibrillator (WCD) for patients with a poor left ventricular ejection fraction (LVEF) who are at risk of sudden arrhythmic death but are not eligible for an implantable defibrillato...
Autores principales: | Quast, A. F. B. E., van Dijk, V. F., Wilde, A. A. M., Knops, R. E., Boersma, L. V. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405026/ https://www.ncbi.nlm.nih.gov/pubmed/28188473 http://dx.doi.org/10.1007/s12471-017-0957-4 |
Ejemplares similares
-
First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011) -
Wearable Cardioverter Defibrillator ― Initial Experience in the Outpatient Setting in Japan ―
por: Horiguchi, Ai, et al.
Publicado: (2020) -
Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021) -
An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016) -
Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)